COMMUNIQUÉS West-GlobeNewswire

Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
04/06/2019
GAITHERSBURG, Md., June 04, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced that John J. Trizzino, Senior Vice President, Chief Business Officer and Chief Financial Officer, will join other vaccine [...]
Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting
04/06/2019
Results Include Data from SVS TCAR Surveillance Project and ROADSTER-2 Study SUNNYVALE, Calif. , June 04, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke [...]
Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine
04/06/2019
GAITHERSBURG, Md., June 04, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced approval by the U.S. Food and Drug Administration (FDA) of the Prior Approval Supplement (PAS) submitted by the [...]
HealthEquity Reports First Quarter Ended April 30, 2019 Financial Results
04/06/2019
Highlights of the first quarter include: Revenue of $87.1 million, an increase of 25% compared to Q1 FY19. Net income of $41.8 million, compared to $22.6 million in Q1 FY19. Includes $17.9 million, net of tax ($23.5 [...]
TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting
04/06/2019
Overall response rate (ORR) of 52% (N=42), with complete response (CR) rate of 19%, by central independent review committee (IRC) Umbralisib was well tolerated with a safety profile that appeared to be maintained with [...]
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
04/06/2019
SAN DIEGO and TORONTO, June 04, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]
Affimed Announces Annual General Meeting of Shareholders
04/06/2019
Heidelberg, Germany, June 04, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancers, announced today that the Annual [...]
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/06/2019
DUBLIN, Ireland, June 04, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
04/06/2019
CRANBURY, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the closing of its previously announced offering of common stock. The Company issued a total of 18,720,930 shares of [...]
XBiotech Announces Closing of Public Offering of Common Shares
04/06/2019
AUSTIN, Texas, June 04, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced the closing of its previously announced underwritten public offering of 4,848,485 of its common shares at a public offering [...]
AB Science is providing a summary of the web conference held on 4 June 2019
04/06/2019
Paris, 4 June 2019, 8pm AB Science outlook for 2019 - Summary of webcast part 1 AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization [...]
AB Science fournit un résumé de la conférence web qui s’est tenue le 4 juin 2019
04/06/2019
Paris, 4 juin 2019, 20h Perspectives d’AB Science pour l’année 2019 Résumé de la première partie de la conférence web AB Science SA (NYSE Euronext – FR0010557264 – AB), société pharmaceutique spécialisée dans la [...]
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at BIO International Convention in Philadelphia
04/06/2019
TORONTO, June 04, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting June 4-6, 2019 at the BIO International Convention in Philadelphia [...]
Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist®
04/06/2019
Five-year Tafinlar + Mekinist survival data presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting and published simultaneously in The New England Journal of Medicine Results are from the [...]
Pathway Health Announces Distribution Agreement with MED-PASS
04/06/2019
LAKE ELMO, Minn., June 04, 2019 (GLOBE NEWSWIRE) -- Pathway Health , a leading post-acute consulting services, strategic technology implementation, and education services firm, has signed a distribution agreement with [...]
Virbac : Declaration of the number of shares and voting rights May 2019
04/06/2019
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote mai 2019
04/06/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Novitium Pharma Launches Generic Revatio® for Oral Suspension, 10mg/mL
04/06/2019
EAST WINDSOR, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Novitium Pharma LLC has received the Food and Drug Administration’s clearance for Sildenafil for Oral Suspension, 10mg/mL. The product is the generic of Pfizer’s [...]
Taconic Biosciences est le premier et le seul vendeur d'animaux à annoncer que toutes ses colonies de souris de laboratoire sont exemptes du nouvel agent pathogène
04/06/2019
RENSSELAER, NEW YORK, 04 juin 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, un leader mondial dans la fourniture de solutions de modèles de rongeurs génétiquement modifiés, a annoncé que toutes ses colonies de souris de [...]

Pages